4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-21-068508
Options or other derivatives
- Chief Scientific Officer acquired 500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Brake Rachael Louise · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-12-06 | Grant or award : show line 1 in the form Stock Option(right to buy) | +500,000 | $0.75 | 2031-12-06 | 500,000 | 500,000 | D |
Loading xslF345X03/doc4.xml…